Accéder au contenu
Merck

Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (2012-03-29)
Fatta B Nahab, Adrian Handforth, Tyler Brown, Christopher Shin, Arnulfo Quesada, Chuanhui Dong, Dietrich Haubenberger, Mark Hallett
RÉSUMÉ

Recent work exploring the use of high-molecular weight alcohols to treat essential tremor (ET) has identified octanoic acid as a potential novel tremor-suppressing agent. We used an established harmaline-based mouse model of ET to compare tremor suppression by 1-octanol and octanoic acid. The dose-related effect on digitized motion power within the tremor bandwidth as a fraction of overall motion power was analyzed. Both 1-octanol and octanoic acid provided significant reductions in harmaline tremor. An 8-carbon alkyl alcohol and carboxylic acid each suppress tremor in a pre-clinical mouse model of ET. Further studies are warranted to determine the safety and efficacy of such agents in humans with ET.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Harmaline, ≥95%